Table 1 Study protocol.

								Primary Endpoint						Secondary Endpoint
Visit after initial IVA		1	2	3	4	5	6	7	8	9	10	11	12	13
Month(s) after initial IVA	Baseline	0	1	2	3	4	5	6	7	8	9	10	11	12
Preceding injection to the follow-up		○	○	○		○		○		○		○
BCVA	○	○	○	○	○	○	○	○	○	○	○	○	○	○
OCT	○	○	○	○	○	○	○	○	○	○	○	○	○	○
FA/ICGA	○				○			○						○
Contrast VA/FVA	○				○			○						○
VFQ-25	○							○						○

IVA, intravitreal aflibercept; BCVA, best-corrected visual acuity; OCT, optical coherence tomography; FA, fluorescein angiography; ICGA, indocyanine green angiography; Contrast VA, contrast visual acuity; FVA, functional visual acuity; VFQ-25, 25-Item Visual Function Questionnaire.

Quick links

Search